focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Ormonde Mining acquires stake in Peak Nickel

Tue, 07th Feb 2023 19:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Haydale Graphene Industries PLC - Ammanford, Wales-based graphene technology company - Says that its "bespoke" mechanical graphene is used to create kayaks for Norse Kayaks. Adds that the Norse kayak is 30% lighter to 16 kilogrammes from 23kg. "The use of graphene has exceeded our expectations and we are sure that this will set a new standard of what is possible to do with a sea kayak. We have never seen this kind of impact strength on light weight sea kayaks in our 20 years' experience in the kayaking business," Norse founder Kjetil Sandvik says.

----------

Tekcapital PLC - London-based intellectual property investor - Launches its Lucyd Lyte 2.0 eyewear. Intends to introduce the product to optical and speciality retail chains worldwide. Notes that it is a "major upgrade" to its flagship Lucyd Lyte audio eyewear platform.

----------

Witan Investment Trust PLC - investment firm - Declares a fourth interim dividend of 1.60p per ordinary share, taking it total dividends for 2022 to 5.80p. Intend to grow its dividend "in real terms," ahead of inflation. Notes that its dividends have grown "substantially" ahead of UK inflation over the past 5 and 10 years.

----------

Ormonde Mining PLC - cash shell, former Dublin-based mineral resource company - Is temporarily suspended from trading on AIM on Wednesday, "pending an announcement and publication of an admission document." Explains that it became a cash shell in October 2022 and was therefore required to announce an acquisition or acquisitions that would be a reverse takeover. Says that it acquired a 20% stake in Peak Nickel Ltd for GBP450,000. Adds that it was granted an option to invest a further GBP4 million in cash in PNL, taking its stake to 49.9% and to buy the remaining 80% of PLN through the issue of Ormonde ordinary shares. Notes that this option can be exercised following the completion of the initial work programme. Notes that the exercise will be dependent on the results of the work programme, among other things, but satisfy the AIM Rule 14 conditions in relation to being a cash shell.

----------

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Files four new patent applications to protect "innovations" around novel gene targets, associated disease-relevant biology and proprietary siRNA stabilisation chemistries. siRNA is short for small interfering RNA. Notes that the new applications build on a period of IP generation in 2022, where a series of patent applications were filed to protect 13 inventions. "This latest announcement of patent filings reflects our continued pace of innovation and progress towards an in-house pipeline of first-in-class RNAi candidates derived from our computational platform. We will continue to build on this progress, maintain the momentum of invention and actively protect our expanding intellectual property portfolio," CEO Ali Mortazavi comments.

----------

Lok'n Store Group PLC - Hampshire, England-based self-storage - Says that its board approved a transition for its shares on AIM to the Stock Exchange Electronic Trading System platform from the London Stock Exchange's Stock Exchange Electronic Trading Service. The move was effective from February 7. Explains that the move is supposed to provide investors with access to the entire SETS system, "providing liquidity via traditional order book trades, as well as firm two-way quotes from market makers."

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
29 Oct 2019 18:49

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Read more
7 Oct 2019 09:14

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

Read more
7 Oct 2019 09:13

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

Read more
13 Aug 2019 12:16

e-Therapeutics Partners With Pharma Firm For Drug Discovery

(Alliance News) - e-Therapeutics PLC on Tuesday said it has agreed to work with an undisclosed global pharmaceutical company, on a project in a specific area of biology, associated with occurs is

Read more
10 Jun 2019 13:33

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in of -

Read more
5 Mar 2019 11:50

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs

LONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the year ended January, the drug discovery

Read more
26 Feb 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

Read more
10 Dec 2018 14:30

E-Therapeutics launches research collaboration with Novo Nordisk

(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more
4 Oct 2018 11:08

e-Therapeutics narrows interim losses as it eyes commercial viability

(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.

Read more
4 Oct 2018 10:31

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs

LONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its costs.For the six months ended

Read more
27 Sep 2018 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 28 September United UtilitiesTrading Statement Baillie Gifford Shin Year 1 events 2 3

Read more
24 May 2018 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.